A new case report published in the Journal of Palliative Medicine reveals the potential of psilocybin-assisted therapy (PAT) to provide relief for patients with terminal brain cancer facing existential distress.
Conducted at McGill University, the study follows a patient with stage 4 astrocytoma who, after conventional treatments failed, found significant psychological relief through PAT—without any negative side effects. Researchers claim this treatment approach could offer a transformative option for those struggling with the emotional toll of a terminal diagnosis.
Traditional therapies had been ineffective in alleviating the patient’s psychological suffering, notes the study. However, after receiving psilocybin-assisted therapy, the patient experienced significant relief from their existential distress without adverse effects. This is a notable finding, as patients with brain cancer have typically been excluded from similar studies.
Continue reading